Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.
2.

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC.

Urol Clin North Am. 2001 Aug;28(3):555-65. Review.

PMID:
11590814
3.

Expectant management of stage A-1 (T1a) prostate cancer utilizing serum PSA levels: a preliminary report.

Loughlin KR, Renshaw AA, Kumar S.

J Surg Oncol. 1999 Jan;70(1):49-53. Review.

PMID:
9989421
4.

Deferred treatment of low grade stage T3 prostate cancer without distant metastases.

Adolfsson J.

J Urol. 1993 Feb;149(2):326-8; discussion 328-9. Review.

PMID:
8426412
5.

[Place of surveillance in the treatment of localized prostate cancer].

Ravery V, Boccon-Gibod L.

Prog Urol. 1999 Apr;9(2):225-30; discussion 229-30. Review. French.

PMID:
10370945
6.

Deferred treatment for clinically localized prostate cancer.

Adolfsson J.

Eur J Surg Oncol. 1995 Aug;21(4):333-6. Review.

PMID:
7664892
7.

The current status of active surveillance for prostate cancer.

Pan DL, Samavedi S, Eldefrawy A, Manoharan M.

Postgrad Med. 2012 May;124(3):50-8. doi: 10.3810/pgm.2012.05.2548. Review.

PMID:
22691899
8.

MRI of localized prostate cancer: coming of age in the PSA era.

Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL.

Diagn Interv Radiol. 2012 Jan-Feb;18(1):34-45. doi: 10.4261/1305-3825.DIR.4478-11.1. Epub 2011 Sep 16. Review.

Supplemental Content

Support Center